Referred to the House Committee on Energy and Commerce.
The bill amends the Public Health Service Act to require group health plans and health insurance issuers to cover, with no cost-sharing, preventive services including prostate cancer screenings for men age 40+ who are at high risk (explicitly including African-American men and men with a defined family history). It defines 'men with a family history of prostate cancer' by several criteria and clarifies which USPSTF breast cancer recommendations are treated as current.
Progressives emphasize reducing racial and familial disparity impacts
Relative to its intended legislative type, this bill is a straightforward statutory coverage mandate that is well-grounded in a clear problem statement and integrated into the existing preventive-services framework, but it omits several implementation and fiscal details that would be expected for a coverage expansion.
The bill amends the Public Health Service Act to require group health plans and health insurance issuers to cover, with no cost-sharing, preventive services including prostate cancer screenings for men age 40+ who are at high risk (explicitly including African-American men and men with a defined family history).
It defines 'men with a family history of prostate cancer' by several criteria and clarifies which USPSTF breast cancer recommendations are treated as current.
The mandate takes effect for plan years beginning on or after January 1, 2026.
Narrow, administrable change with potential bipartisan support, but medical controversy, race-based language, and Senate procedure reduce likelihood.
Relative to its intended legislative type, this bill is a straightforward statutory coverage mandate that is well-grounded in a clear problem statement and integrated into the existing preventive-services framework, but it omits several implementation and fiscal details that would be expected for a coverage expansion.
Progressives emphasize reducing racial and familial disparity impacts
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize reducing racial and familial disparity impacts
Likely supportive because the bill expands access to early detection for groups with higher mortality and addresses racial and familial risk disparities.
It reduces financial barriers and could improve early-stage diagnosis and survival among high-risk men.
Cautiously favorable if the bill is paired with clear evidence-based screening protocols and monitoring.
Appreciates reducing barriers for high-risk groups but wants safeguards on overdiagnosis, cost impacts, and administrative clarity.
Likely opposed due to expanding federal insurance mandates and removing cost-sharing, increasing government direction of medical decisions.
Concerned about overutilization, higher premiums, and state flexibility being constrained.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, administrable change with potential bipartisan support, but medical controversy, race-based language, and Senate procedure reduce likelihood.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize reducing racial and familial disparity impacts
Narrow, administrable change with potential bipartisan support, but medical controversy, race-based language, and Senate procedure reduce l…
Relative to its intended legislative type, this bill is a straightforward statutory coverage mandate that is well-grounded in a clear problem statement and integrated into the existing preventive-services framework, but…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.